[Adverse effects of therapeutic drugs on neuromuscular junctions].
Motomura
Masakatsu
M
Shiraishi
Hirokazu
H
Yoshimura
Toshiro
T
Tsujihata
Mitsuhiro
M
D000617:Aminoglycosides / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001323:Autoantibodies; D001569:Benzodiazepines / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects; D017616:Magnesium Compounds / Q000009:adverse effects; D009157:Myasthenia Gravis / Q000209:etiology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010396:Penicillamine / Q000009:adverse effects; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology